Theravance Biopharma Stock Performance
as on August 20, 2026 at 6:59 am IST
Day's Low
Day's High
$16.98$17.00
0.06%
Downside
0.06%
Upside
52 Week's Low
52 Week's High
$13.08$21.0323.01%
Downside
23.78%
Upside
Theravance Biopharma share price movements today
- Previous Close
- $16.95
- Open
- $17.00
- Volume
- 230.3K
- Market Cap
- $881.1M
- Day's Low - High
- $16.98 - $17.00
- 52 Week Low - High
- $13.08 - $21.03
Theravance Biopharma Historical Returns
- 1 Month Return
- + 0.24 %
- 3 Month Return
- + 4.62 %
- 1 Year Return
- + 29.05 %
- 3 Year Return
- + 76.22 %
- 5 Year Return
- + 32.58 %
Theravance Biopharma Stock Fundamentals & Key Indicators
Check Theravance Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$881.1M
EPS (TTM)
0.21
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
16.32
Industry PE ratio
-7.283372093023256
PEG Ratio
-0.05
EBITDA
11.1M
Revenue (TTM)
104.3M
Profit Margin
51.58%
Return On Equity TTM
20.91%
Theravance Biopharma Stock Valuation
Track how Theravance Biopharma P/E has moved over time to understand its valuation trends.
Theravance Biopharma in the last 5 years
Lowest (-46.33x)
March 31, 2024
Industry (-7.28x)
August 17, 2026
Today (16.32x)
August 17, 2026
Highest (92.49x)
June 30, 2026
Today’s Price to Earnings Ratio: 16.32x
Theravance Biopharma vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Theravance Biopharma with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $881.1M | 32.58% | 16.32 | 51.58% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Theravance Biopharma Stock including INR - Dollar returns
The Theravance Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Theravance Biopharma investment value today
Current value as on today
₹1,42,071
Returns
₹42,071
(+42.07%)
Returns from Theravance Biopharma Stock
₹29,202 (+29.2%)
Dollar Impact
₹12,870 (+12.87%)
Analyst Recommendation on Theravance Biopharma Stock
Based on 3 analysts
0.00%
Buy
100.00%
Hold
0.00%
Sell
Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Theravance Biopharma. Average target price of $17.67
Theravance Biopharma Share Price Target
Get share price movements and forecasts by analysts on Theravance Biopharma.
What analysts predicted
3.85%UPSIDE
Target Price
$17.67
Current Price
$16.99
Analyzed by
3 Analysts
Target
$17.67
Theravance Biopharma target price $17.67, a slight upside of 3.85% compared to current price of $16.99. According to 3 analysts rating.
Indian Investors' Interest in Theravance Biopharma Stock
Search interest for Theravance Biopharma Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Theravance Biopharma Quarterly Profit & Loss
All numbers in Millions USD
Theravance Biopharma Annual Profit & Loss
All numbers in Millions USD
Theravance Biopharma Quarterly Cash Flow
All numbers in Millions USD
Theravance Biopharma Annual Cash Flow
All numbers in Millions USD
Theravance Biopharma News & Key Events
Today's Timeline - 29 June
Mon, 06:14 PM
-Zymeworks to acquire Theravance for $17 per share, totaling $929 million, with contingent value rights for shareholders.
Insights on Theravance Biopharma
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 17.69M → 20.73M (in $), with an average increase of 14.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 years, TBPH stock has moved up by 74.7%
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 629.2% return, outperforming this stock by 554.5%
- NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 465.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 61.02M → -5.89M (in $), with an average decrease of 63.8% per quarter
About Theravance Biopharma
| Organisation | Theravance Biopharma |
| Headquarters | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Biotechnology |
| CEO | Mr. Rick E. Winningham M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Theravance Biopharma
Name | Title |
|---|---|
Mr. Rick E. Winningham M.B.A. | CEO & Director |
Ms. Rhonda F. Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs |
Dr. Aine Miller Ph.D. | Senior VP of Development & Head of Ireland Office |
Mr. Aziz Sawaf C.F.A. | Senior VP of Operations Strategy & CFO |
Mr. Stuart Knight | Senior VP of IT&I and Chief Information Officer |
Mr. Brett A. Grimaud Esq. | Senior VP, General Counsel & Secretary |
Ms. Stacy L. Pryce | Senior VP & Chief Strategy Officer |
FAQs
What is Theravance Biopharma share price today?
Theravance Biopharma share price today is $16.99 as on at the close of the market. Theravance Biopharma share today touched a day high of $17.00 and a low of $16.98.
What is the 52 week high and 52 week low for Theravance Biopharma share?
Theravance Biopharma share touched a 52 week high of $21.03 on and a 52 week low of $13.08 on . Theravance Biopharma stock price today i.e. is closed at $16.99,which is 19.21% down from its 52 week high and 29.89% up from its 52 week low.
What is Theravance Biopharma's market capitalisation today?
Theravance Biopharma market capitalisation is $0.00T as on .
How to invest in Theravance Biopharma Stock (TBPH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Theravance Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Theravance Biopharma Shares that will get you 0.0883 shares as per Theravance Biopharma share price of $16.99 per share as on August 20, 2026 at 1:29 am IST.
What is the minimum amount required to buy Theravance Biopharma Stock (TBPH) from India?
Indian investors can start investing in Theravance Biopharma (TBPH) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Theravance Biopharma stock (as per the Rupee-Dollar exchange rate as on ).
Based on Theravance Biopharma share’s latest price of $16.99 as on August 20, 2026 at 1:29 am IST, you will get 0.5886 shares of Theravance Biopharma. Learn more about
fractional shares .
What are the returns that Theravance Biopharma has given to Indian investors in the last 5 years?
Theravance Biopharma stock has given 32.58% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?